Your Gateway to (some of) $27.4 Billion?

Posted On Sep 23, 2021 By Addison Wiggin

Watching the market’s ups and down while waiting for the fall has made us pretty anxious. In fact, the past year and a half hasn’t been good for anyone’s mental health. According to the Centers for Disease Control, the number of adults showing signs of an anxiety or depressive disorder jumped 5% between August 2020 and February 2021. That’s why I was very interested in what Ray Blanco had to say about Cybin Inc. (CYBN), a company working on a unique treatment for mental disorders. Its drug “could be powerful therapeutic tools for stuff that we can’t treat right now, like treatment-resistant depression, addiction, post-traumatic stress disorder and things like that” — giving it a huge advantage in a $27.4 billion market.

Subscribe to Platinum Reserve Today!

From blue chips to penny stocks, income plays to growth opportunities, commodities to techs, ETFs to OTCs, bonds to options — the Agora Financial Platinum Reserve covers it all. You simply cannot find a more comprehensive source of investment analysis and recommendations.

Subscribe Today!